Meet the Analyst: Thomas Wakim & John Hester, Bell Potter Analyst

Join us as we conclude our 2024 Meet the Analyst series with a bang. Our Market Analyst, Grady Wulff, sits down with Bell Potter Securities’ analysts John Hester and Thomas Wakim for a comprehensive discussion on the healthcare sector.
From deciphering Neuren Pharmaceuticals (ASX:NEU) share price fluctuations to anticipating the news flow that will share 2025 guidance and identifying why Telix Pharmaceuticals (ASX:TLX) and Clarity Pharmaceuticals (ASX:CU6) are stocks to watch in the new year, John and Thomas cover it all in this final episode of the year.
In this video, John and Thomas discuss:
• (1:48): the headwinds & tailwinds facing the healthcare sector
• (7:10): why they are bullish on Neuren
• (13:48): opportunities in healthcare stocks for 2025
• (15:18): what's on their clinical data radar for the upcoming year.
Note: this interview was filmed on 10 December 2024.
Find Bell Direct here:
Twitter: / belldirect
Facebook: / belldirectau. .
LinkedIn: / bell. .
Instagram: / bell.direct
Threads: www.threads.ne...